以色列 - 希伯来文 - Ministry of Health

novartis pharma services ag - amlodipine as besylate 10 mg; valsartan 320 mg - film coated tablets - valsartan - exforge ( amlodipine and valsartan) is insicated for the treatment of hypertension. this fixed combination drug is not indicated for the initial therapy of hypertension.

以色列 - 希伯来文 - Ministry of Health

unipharm ltd, israel - atorvastatin as magnesium - טבליה - atorvastatin as magnesium 20 mg - atorvastatin - atorvastatin - atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains

以色列 - 希伯来文 - Ministry of Health

unipharm ltd, israel - atorvastatin as magnesium - טבליה - atorvastatin as magnesium 40 mg - atorvastatin - atorvastatin - atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains

以色列 - 希伯来文 - Ministry of Health

unipharm ltd, israel - atorvastatin as magnesium - טבליה - atorvastatin as magnesium 80 mg - atorvastatin - atorvastatin - atorvastatin is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. atorvastatin is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains

以色列 - 希伯来文 - Ministry of Health

teva pharmaceutical indust.ltd - rosuvastatin as calcium 10 mg - tablets - rosuvastatin - primary hypercholesterolaemia (type iia including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type iib) as an adjunct to diet when response to diet and other non-pharmacological treatments (e.g. exercise weight reduction) is inadequate. homozygous familial hypercholesterolaemia as adjunct to diet and other lipid lowering treatments (e.g. ldl apheresis) or if such treatments are not appropriate.

以色列 - 希伯来文 - Ministry of Health

teva pharmaceutical indust.ltd - solifenacin succinate 10 mg - tablets - solifenacin - solifenacin is indicated for symptomatic treatment of urge incontinence and/or urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

以色列 - 希伯来文 - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 10 mcg - alprostadil - alprostadil - for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic or mixed etiology. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

以色列 - 希伯来文 - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 10 mcg - alprostadil - alprostadil - for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic or mixed etiology. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

以色列 - 希伯来文 - Ministry of Health

pfizer pharmaceuticals israel ltd - pegvisomant - אבקה וממס להכנת תמיסה להזרקה - pegvisomant 10 mg - pegvisomant - pegvisomant - treatment of patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.

以色列 - 希伯来文 - Ministry of Health

gramse pharmaceuticals ltd - oxytocin 10 iu/ml - solution for injection - oxytocin - induction of labor for medical reasons. stimulation of labor in hypotonic uterine inertia. during caesarian section following the delivery of the child. prevention and treatment of postpartum uterine atony and haemorrhage. oxytocin may also be indicated in early stages of pregnancy as an adjunctive therapy for the management of incomplete, inevitable or missed abortion.